First Pacific Financial Abbott Laboratories Transaction History

First Pacific Financial

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$109.52 - $120.96 $6,461 - $7,136	59 New	59 $6,000
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $708,476 - $783,781	-6,073 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$105.79 - $124.53 $81,140 - $95,514	767 Added 14.46%	6,073 $704,000
Q1 2021 May 03, 2021	BUY	$108.84 - $128.23 $114,064 - $134,385	1,048 Added 24.61%	5,306 $636,000
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $447,090 - $487,200	4,258 New	4,258 $466,000

3,336

1.36B

10M

9.48M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of First Pacific Financial, based on Form 13F filings with the SEC.

Stay updated on First Pacific Financial with notifications on news.